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Background: The relationship between cardiac output and septic acute kidney injury (AKI) remains unclear. The
purpose of this study was to assess the association between the cardiac index (CI) and the renal outcomes in
patients with septic shock.
Methods: A one-year prospective cohort study was performed in the surgical and medical ICU of a teaching hospital
in Nanjing, China. Twenty-nine septic shock patients who required early goal-directed fluid resuscitation were
consecutively included. Pulse indicator continuous cardiac output (PiCCO) device was used to measure hemodynamic
parameters before and after early goal-directed therapy (EGDT). Based on CI changes after EGDT, patients were assign
to the CI increased group or the CI constant group, respectively. The incidence of poor renal outcome, which was
defined as AKI on admission without recovery in following three days or new onset AKI within 28 days, was recorded.
We investigated whether an increased CI was associated with a better renal outcome.
Results: After EGDT, there were 16 patients in the CI increased group and 13 patients in the CI constant group. The
incidence of poor renal outcome was lower in CI increased group than in the CI constant group (6% vs. 62%; P = 0.003)
with a relative risk of 0.10. The logistic regression showed that the CI percent change was associated with renal
outcome, with an odd ratio of 0.003 (P = 0.056) after adjustment of possible confounding factors. The CI percent
change would predict a good renal outcome (AU ROC 0.739, P = 0.012) with moderate accuracy (sensitivity 75%
and specificity 89%) when using a 10% cut-off value from Youden index. The CI percent change was also positively
correlated with creatinine clearance (CCr) after EGDT (ρ = 0.548; P = 0.002).
Conclusions: The increased CI after EGDT was a protective factor for kidney in patients with septic shock. A CI
increased above 10% could be potentially used to predict development and reversibility of AKI in septic shock patients.
Trial registration: Clinicaltrials.gov:NCT01862588 (May 13, 2013).
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As a common comorbidity among septic shock patients,
acute kidney injury (AKI) prolongs hospitalization and
increases mortality [1-4]. Due to compensatory renal vaso-
constriction and right shifting of renal blood flow auto-
regulation curve, the renal hypo-perfusion becomes the
leading cause of septic AKI [5,6]. Since the organ perfu-
sion was proven to be affected by systemic hemodynamics,
early goal-directed therapy (EGDT), which aims to correct
circulatory failure [7], may prevent AKI.* Correspondence: haiboq2000@163.com
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unless otherwise stated.Kidney perfusion could be improved through increas-
ing the mean arterial press (MAP) by implement of va-
sopressors or fluid infusion. Vasopressors may, however,
increase the renal vascular resistance, which result in a
decrease in renal blood flow [8], making it difficult to set
a MAP goal to attenuate AKI [9,10]. In addition, achiev-
ing a high MAP goal was related to fluid overload, which
may increase the risk of AKI [11,12].
Hyper-dynamic circulation was usually characterized
as a high cardiac output. It was more a sign of cardiac
compensation, which may lead to a better blood supply
in septic shock [13,14]. An increase in cardiac output can
be interpreted as an improvement in perfusion, and is
associated with restoration of renal blood flow. [14,15].is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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with AKI shared low cardiac index (CI) and higher cen-
tral venous pressure (CVP) after resuscitation [16,17], sug-
gesting the cardiac output may play an important role
during the development of septic AKI.
This prospective cohort study was designed to investi-
gate the relationship between CI and the renal outcomes,
with the aim of evaluating the possibility of setting a CI
goal for renal protection.Methods
Patients
This non-interventional study was conducted in a 30-bed
surgical and medical intensive care unit (ICU) at a teach-
ing hospital affiliated to Southeast University in China.
The protocol was approved by Jiangsu institutional Ethics
Committee (Approval Number: 2013ZDSYLL075.0), and
written informed consent was obtained from patients or
their legally authorized representative. The trial was regis-
tered at clinicaltrial.gov (NCT01862588).
From January to December 2013, patients admitted into
our ICU with documented or suspected septic shock [18]
were prospectively screened. Eligibility criteria included a
suspected or confirmed infection, two or more criteria for a
systemic inflammatory response, and hypotension persist-
ing after initial fluid challenge or blood lactate >4 mmol/L
[19]. Exclusion criteria were pregnancy, age <18 years,
achieved EGDT goals already on admission, contraindi-
cation of invasive catheter, ongoing recovery from AKI,
severe chronic renal failure defined by a glomerular-
filtration rate (GFR) <30 m/min/1.73 m2 [20], as well as
conditions known to modify renal perfusion, such as
renal-artery stenosis and severe intra-abdominal hyper-
tension (>25 mmHg) [21].Figure 1 Flowchart of patients included in the study. EGDT, early goal-
continuous cardiac output; CI, cardiac index.Study protocol
(1) After admission to the ICU, blood cultures were
drawn, antibiotics were administered, and fluid infusion
were initiated (2) A pulse indicator continuous cardiac
output (PiCCO) device, including internal jugular vein and
femoral artery catheters, was placed immediately after
getting consent. The hemodynamic parameters were
collected through the thermo-dilution method. (3) Due
to the observational nature of the study, the physician
implemented the EGDT according to the guidelines [19].
(4) After achieving the EGDT goals (CVP 8 to 12 mmHg,
MAP ≥ 65 mmHg, urine output (UO) ≥0.5 ml/kg/hr
and central venous oxygen saturation (ScvO2) ≥ 70% [7])
and allowing patient to stabilize for 30 minutes, the
hemodynamic parameters were recorded again. (5) Data
collected from patients who achieved EGDT goals within
12 hrs were analyzed, and divided into two groups based
on CI changes. Patients were followed up for 28 days, or
until death, monitoring the development of AKI.
Data collection
The basic characteristics such as age, mechanical venti-
lation, acute physiology and chronic health evaluation
score II (APACHE score II), and infection site were col-
lected. Hemodynamic parameters, including CVP, MAP,
ScvO2, CI, stroke volume index (SVI), systemic vascular
resistance index (SVRI), global end-diastolic volume index
(GEDI), global ejection fraction (GEF), cardiac function
index (CFI), and arterial lactate acid (Lac), were recorded.
Additionally, 2-hr urine output, serum creatinine (Cr),
serum urea nitrogen (BUN), serum neutrophil gelatinase-
associated lipocalin (NGAL, ELISA kit, Uscn Life Science
Inc, Wuhan, PRC), urine creatinine, creatinine clearance
(CCr) and fractional excretion of sodium (FeNa) were also
recorded before and after EGDT. The height and weightdirected therapy; CKD, chronic kidney disease; PiCCO, Pulse indicator
Table 1 Patients’ characteristics
CI constant CI increased P value
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tients or their next of kin.group (n = 13) group (n = 16)
Age (years) 78(69–86) 75(65–83) 0.29
Males n (%) 7(54) 8(50) 1.00
Hypertension n (%) 9(69) 10(63) 1.00
Diabetes mellitus n (%) 5(38) 4(25) 0.69
Source of infection
Lungs n (%) 6(46) 10(63) 0.47
Abdomen n (%) 7(54) 4(25) 0.14
Soft tissue n (%) 0(0) 1(6) 1.00
Other n (%) 0(0) 1(6) 1.00
APACHE score II 24(24–30) 23(19–27) 0.13






0.3(0.1-0.4) 0.2(0.2-0.4) 0.36Outcome measures
The primary end point was poor renal outcome at day
28. For each patient, the incidence of AKI was evaluated
according to the Kidney Disease: Improving Global
Outcomes (KDIGO) criteria [22], which proposed criteria
for three stages of increasing severity. The basal serum
creatinine level was set as the lowest value in the 3 months
preceding inclusion. If no serum creatinine were available,
the lowest value during ICU stay (during renal recovery)
or average level of same age bracket among Chinese
population [23] was used to assess underlying renal func-
tion. Poor renal outcome was defined as persistent AKI
(KDIGO stage 2–3 on admission and did not recover to
stage 0–1 in 3 days) or development of new AKI (KDIGO
stage 2–3) [16,24]. The secondary end point was mortality
























Persistent AKI n (%) 4(31) 1(6) 0.14Statistics
Data are presented as median and interquartile range or
number and percentage, as appropriate. Categorical vari-
ables were compared using the Fisher’s exact test, continu-
ous variables were compared using several tests: for pre
and post measurements, the nonparametric Wilcoxon test
was used; for pairwise comparisons, the Mann–Whitney
test; for comparisons across the three group, the Kruskal-
wallis test. Receiver operating characteristic (ROC) curves
and Youden index were used to choose the appropriate
cutoff points. The relationships between variables were
evaluated through the use of Spearman correlation. Logistic
regression analysis, with or without adjustment for po-
tential confounding factors, was used to confirm the
correlation. A significance level 0.05 was chosen for all
tests in SPSS 17.0 software.AKI 0-1on admission
n (%)
7(54) 12(75) 0.27




Days in ICU (days) 8(6–14) 8(7–19) 0.98
28-day mortality n (%) 6(46) 5(31) 0.47
CI, cardiac index; APACHE, Acute physiology, age, chronic health evaluation;
SOFA, sequential organ failure assessment. The data in the table are expressed
as median (interquartile range) or number (%).Results
Patients’ characteristics
Twenty-nine septic shock patients were included after
screening and application of selection criteria (Figure 1).
Considering the systemic error of thermo-dilution method,
a cut-off value of 10% for CI increase [25] was used.
In total, we observed 16 patients with CI increase (CI
increased group) and the rest 13 patients were divided
in CI constant group. Factors such as age, hypertension or
diabetes mellitus, APACHE score II, the use of vasopres-
sors or resuscitation fluid, 28-day mortality, etc. made no
significant difference between both groups (Table 1). Yet,
the levels of CI, SVI, GEF and CFI after EGDT were
higher in the CI constant group than those in the CI
increased group (Table 2).Relationship between CI changes and renal function
during resuscitation
After EGDT, the urine output and CCr increased in CI
increased group while decreased in CI constant group
(Table 3). The median CCr after resuscitation was higher
in CI increased group than in CI constant group (Table 3).
Table 2 Hemodynamic parameters before and after EGDT
CI constant group (n = 13) CI increased group (n = 16) P value
HR (beats/min) Before EGDT 113(90–134) 117(87–130) 0.69
After EGDT 91(73–114) 95(78–107) 0.76
P value 0.002 0.013
MAP (mmHg) Before EGDT 65(58–73) 64(55–67) 0.60
After EGDT 87(69–98) 86(76–93) 0.96
P value 0.002 <0.001
CVP (mmHg) Before EGDT 10(5–12) 6(4–11) 0.56
After EGDT 10(8–15) 11(8–15) 0.89
P value 0.045 0.004
CI (L/min/m2) Before EGDT 3.2(2.7–4.3) 2.6(2.2–3.2) 0.06
After EGDT 3.0(2.6–4.0) 3.8(3.1–5.2) 0.028
P value 0.022 <0.001
SVI (ml/m2) Before EGDT 34(28–37) 29(23–36) 0.14
After EGDT 36(32–38) 43(40– 48) 0.003
P value 0.11 <0.001
SVRI (dyn.s.m2/cm5) Before EGDT 1478(1231–2076) 1722(1497–2373) 0.34
After EGDT 1652(1273–2391) 1545(1185–1881) 0.43
P value 0.06 0.163
GEDI (ml/m2) Before EGDT 793(670–936) 651(634–771) 0.035
After EGDT 878(673–1056) 767(697–886) 0.50
P value 0.17 <0.001
GEF (%) Before EGDT 15(13–20) 17(16–22) 0.19
After EGDT 16(13–20) 23(20–24) 0.012
P value 0.36 0.013
CFI (L/min) Before EGDT 4.0(3.2–5.3) 4.2(3.7–4.9) 0.96
After EGDT 3.8(2.9–4.5) 5.0(4.4–5.9) 0.003
P value 0.008 0.003
ScvO2 (%) Before EGDT 80(73–85) 79(76–81) 0.66
After EGDT 80(75–83) 84(81–84) 0.026
P value 0.81 0.005
Lac (mmol/L) Before EGDT 3.2(1.5–5.1) 2.4(1.3–3.3) 0.44
After EGDT 1.7(1.2–2.8) 1.3(0.9–1.7) 0.25
P value 0.039 0.03
MAP, mean arterial pressure; CVP, central venous pressure; HR, heart rate; CI, cardiac index; SVI, stroke volume index; SVRI, systemic vascular resistance index;
GEDI, global end-diastolic volume index; GEF, global ejection fraction; ScvO2, central venous oxygen saturation; Lac, arterial lactate acid. The data in the table are
expressed as median (interquartile range) or number (%).
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change associated with CCr percent change (ρ = 0.524;
P = 0.004) and CCr level after resuscitation (ρ = 0.548;
P = 0.002) (Figure 2).
Relationship between CI changes and renal outcomes
The incidence of poor renal outcomes was lower in CI
increased group than in the CI constant group (6% vs.
62%; P = 0.003) with a relative risk of 0.10. The single-
factor analysis also shown that the CI percent change(33% [2% to 59%] vs. 0 [−10% to 8%]; P = 0.043) differed
between patients with different renal outcomes. After
adjustment of possible confounding factors (GEDI percent
change: OR= 1.625, P = 0.910; APACHE score II: OR=
1.067, P = 0.598; total resuscitation fluid amount: OR= 1.038,
P = 0.365; basal serum Cr level: OR= 0.987, P = 0.229), the
OR between CI percent change and poor renal outcome was
0.003 (P = 0.056). The CI percent change had a moderate
predictive accuracy of AKI recovery with an area under the
ROC curve of 0.739(P = 0.012) (Figure 3). A cutoff
Table 3 Renal function parameters before and after EGDT
CI constant group (n = 13) CI increased group (n = 16) P value
Serum Cr(umol/L) Before EGDT 68(49–261) 83(56–133) 0.74
After EGDT 83(55–215) 76(63–127) 0.86
P value 1.0 0.98
Serum Bun(mmol/L) Before EGDT 8.4(4.9-14.4) 7.8(5.7-10.0) 0.61
After EGDT 8.5(4.5-14.8) 7.9(4.7-9.0) 0.65
P value 0.27 0.27
Serum NGAL(ng/ml) Before EGDT 140(70–375) 74(28–148) 0.11
After EGDT 169(60–254) 125(60–179) 0.55
P value 0.68 0.048
Urinary Cr(umol/L) Before EGDT 4010 (2395–9143) 7894(3424–9910) 0.24
After EGDT 2766(2100–8817) 3642(2174–7375) 0.69
P value 0.60 0.004
Urine output(ml/h) Before EGDT 85(40–128) 73(23–119) 0.35
After EGDT 67(43–128) 98(70–150) 0.11
P value 0.31 0.013
Ccr (ml/min) Before EGDT 85(17–129) 59(45–101) 0.69
After EGDT 53(22–93) 82 (52–126) 0.08
P value 0.034 0.12
FeNa(%) Before EGDT 0.6(0.1-12.3) 0.7(0.3-1.5) 0.64
After EGDT 1.0(0.1-8.9) 1.0(0.5-1.8) 0.83
P value 0.53 0.41
Cr, creatinine; Bun, urea nitrogen; NGAL, neutrophil gelatinase-associated lipocalin; Ccr, creatinine clearance; FeNa, fractional excretion of sodium. The data in the
table are expressed as median (interquartile range) or number (%).
Figure 2 The relationship between cardiac index percent change
and creatinine clearance after resuscitation. Correlations were
assessed by using Spearman regression model. Figure 2 shows a
significant positive correlation between CI percent change and Ccr
after resuscitation (ρ = 0.548; P = 0.002).
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index would reach a sensitivity of 75% and a specificity
of 89%.
Relationship between CI after EGDT and renal outcome
Based on a retrospective study [17] which reported that
a much high cardiac output was associated with worse
outcome, we divided patients into three groups according
to the CI after EGDT. The incidence of poor renal out-
comes was 44% (4/9) in patients with a CI < 3.0 L/min/m2,
10% (1/10) in patients with a CI 3.0-4.0 L/min/m2 and
40% (4/10) in patients with a CI > 4.0 L/min/m2, however,
no statistical differences were observed (P = 0.20) (Table 4).
The CI after EGDT was not sufficient to predict renal
outcome with an area under the ROC curve of 0.556
(P = 0.115) (Figure 3).
Discussion
The present study demonstrated that the increased CI
during EGDT was a protective factor of AKI. The in-
creased CI was not only associated with better renal func-
tion, but also associated with better renal outcome.
Renal hypo-perfusion was one of the main causes of
septic AKI [6], thus restoration of renal blood flow may
benefit kidney. Hyper-dynamic circulation, characterized
Figure 3 Receiver-operating characteristic (ROC) curve depicting
the cardiac index (CI) percent change (%) or CI after early goal-
directed therapy (EGDT) to predict good renal outcome. The area
under ROC curves were 0.739(P = 0.012) of CI percent change to
predict non-poor renal outcome. A cutoff value of 10% determined
by Youden index would provide a sensitivity of 89% and a specificity of
75%. The area under ROC curves were 0.556(P = 0.115) of CI after EGDT
to predict non-poor renal outcome. A cutoff value of 3.0 L/min/m2
determined by Youden index would provide a sensitivity of 56%
and a specificity of 75%.
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and would lead to better perfusion of organs, including
heart, brain, liver, guts, and especially the kidney [13-15].
In animal sepsis studies conducted by Langenberg, et al.,
increased renal blood flow along with cardiac output was
also observed [15,26,27]. In this study, despite lacking ofTable 4 Relation between hemodynamic parameters and outc
CI < 3.0 L/min/m2 (n = 9) CI 3
Age (years) 81(76–86) 75(
APACHE score II 24(20–25) 24(
CVP after EGDT(mmHg) 8(7–11) 13(
GEDI after EGDT(ml/m2) 722(613–970) 785
MAP after EGDT(mmHg) 95(85–102) 85(
ScvO2 after EGDT(%) 82(74–85) 81(
Norepinephrine (ug/kg/min) 0.1(0–0.3) 0.3(
Hydroxyethyl starch n (%) 5(56) 6(6
Hydroxyethyl starch amount (ml/kg) 10.0(7.1-12.2) 9.0(
Resuscitation fluid amount(ml/kg) 31.7(19.4-37.9) 33.9
Poor renal outcome n (%) 4(44) 1(1
28-day mortality n (%) 4(44) 3(3
CI, cardiac index; APACHE, Acute physiology; CVP, central venous pressure; GEDI, gl
venous oxygen saturation; The data in the table are expressed as median (interquadirect renal perfusion monitoring, we observed that
the CCr was increasing together with CI changes dur-
ing EGDT, suggesting the kidney may benefit from im-
provement of global circulation. Furthermore, the renal
outcome in CI increased group was better than CI con-
stant group, and a regression analysis has confirmed in-
creased CI was a protective factor for kidney after
adjusting any possible confounding factors.
The survival sepsis campaign guidelines well promoted
the early initiation of fluid and vasopressors in patients
with septic shock. Most patients had already received
different doses of fluid before admitted to ICU (in the
emergency department or even in the ambulance) and
13 patients in our study complete 3 of the 4 EGDT goals
when admitted. However, the EGDT goals, as the funda-
mental targets, were not the endpoint of early resuscita-
tion [7,28,29]. In this study, the great improvement of
MAP, HR, Lac during the early resuscitation were observed,
suggesting a potential space for progression, which enabled
us to further investigate the benefits of increased CI.
Various reasons might contribute to the constant CI in
part of patients. Physiologically, the cardiac output is de-
termined by the volume status and fluid responsiveness.
After EGDT, though receiving same dose of fluid, the
volume status parameters (CVP or GEDI) increased ap-
parently in CI increased group, suggesting a better fluid
responsiveness with these patients. The higher CVP and
GEDI in the CI constant group before EGDT indicated a
sign of more sufficient blood volume, and further infu-
sion of fluid would not transfer to more cardiac output
(Starling principle). Besides, the reduction of myocardial
contractility usually results from sepsis, which was induced
by myocardial depression [30]. It may also play a role in
the absence of fluid responsiveness. We noticed that,
concerning the similar volume status (before EGDT inomes
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creased group), the SVI, GEF and CFI were lower in the
CI-increased group, and they may show a significant
difference in myocardial contractility between groups
(Table 2).
Though increased cardiac output may attenuate poor
renal outcome, we failed to define a CI goal which has
the minimal risk of AKI. Based on a previous research
[17], either a much lower or higher cardiac output may
be harmful. When divided patients into three groups,
the incidence of poor renal outcome distributed in valley
form and a CI between 3.0-4.0 L/min/m2 seems less
likely to develop AKI. There may be two hypotheses for
the phenomenon: First, a higher cardiac output not only
increases oxygen deliver for the kidney, but also brings
harmful inflammatory factors or oxygen free radicals
[31]; Second, it is likely that a higher cardiac index is a
sign of worse sepsis with poor oxygen extraction and
higher compensated perfusion [32], and therefore these
patients were more prone to develop AKI. Though it was
necessary to evaluate an upper limit of cardiac output
goal, however, the area under ROC curve was not good
enough to determine a CI goal based on our present data.
Renal protection needs an accurate prediction on de-
velopment and progression of AKI. However, evaluation
for the AKI risk remained uncertainty. Although the AKI
biomarker and renal Doppler were two promising methods
for AKI evaluation [33,34], they were either too complex
or expensive to be widely accepted by clinical physicians
and technicians. Our study had demonstrated that the CI
changes were correlated with renal outcomes, which a 10%
CI increased could be used as an indicator. Besides, the CI
could be easily monitored at bedside, which made itself
more applicable in critical care departments.Limitations
Our study had several limitations. First, being completely
blind to the patients’ clinical conditions seemed almost
impossible. So a doctor who was unaware of our research
details designed the fluid resuscitation plans. Moreover,
the sample size was not considerable quantity even though
we have adequate power, the study needs to be repeated in
a larger, multicenter cohort. Only those patients who
had received PiCCO monitor were included in current
research, which might introduce bias. Additionally, pa-
tients who had received treatment in emergency depart-
ment and those who had already achieved EGDT goals
during ICU admission were excluded, therefore potentially
the sample size was reduced. Finally, some patients re-
ceived infusion of hydroxyethyl starch during resuscita-
tion, which may affect renal function as well. However,
there were no significant differences in portions or doses
of hydroxyethyl starch between groups.Conclusion
In this study, we found that increased CI during EGDT
was associated with a better renal outcome and could be
potentially used to predict the development or progres-
sion of AKI. Targeting a 10% CI increment for reducing
the risk of AKI should be considered in this setting.
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